Publications Alert

by | 18 Apr 2017

Patient engagement in practice
Patient engagement in practice

‘Improving Patient Involvement in Medicines Research and Development: A Practical Roadmap’ has just been published in Therapeutic Innovation & Regulatory Science. Authored by PFMD’s Jan Geissler and co-authors Bettina Ryll, Mary Burke Uhlenhopp and Susanna Leto Zavka. Access the full article here.

Tags:

What expertise is required to make an impact in patient engagement?

by | May 12, 2022

New European health partnership promises to boost patient involvement 

by | March 25, 2022

Remuneration for patients interacting with the Pharma industry: strong support to develop Global Principles

by | February 16, 2022

Are cardiovascular patients ready for the digital revolution? 

by | December 13, 2021

How tailored training and guidance could help medtech involve patients

by | October 27, 2021

Patient remuneration: have your say

by | October 25, 2021

Wanted: a global approach to patient remuneration

by | October 6, 2021

Fast-moving medtech accelerating pivot towards patient engagement

by | September 14, 2021

Medtech & patient engagement: could ‘quick wins’ help industry respond to a growing trend? 

by | September 14, 2021

Digital health: how patients can shape responsible data management 

by | August 23, 2021

Hearing the voices of children in medicines R&D

by | August 23, 2021

The use of patient experience data is reaching a ‘tipping point’, say experts

by | July 19, 2021

PEOF 2021: Patient Engagement to design, generate, analyze and decide on Patient Experience Data

by | June 18, 2021

Co-creation in patient engagement – “it’s time to roll up our sleeves”

by | June 18, 2021

From PE Metrics Framework to Actionable Tool – What’s After PARADIGM? 

by | June 18, 2021

PEOF 2021 How to Connect Patients to Digital Health

by | June 11, 2021

Putting cardiovascular patients at the heart of the technology revolution

by | June 3, 2021

The road to patient-centred medtech

by | May 28, 2021

Parkinson’s disease: what medtech companies can learn from patients

by | May 17, 2021

Virtual events: tips for patient organisations

by | March 4, 2021

The challenges of engaging patients with rare diseases 

by | February 26, 2021

Coping with COVID: Pandemic putting pressure on vulnerable patients 

by | February 3, 2021

“A pioneering opportunity”: piloting the first How-To Guide

by | January 26, 2021

Meaningful patient engagement proved “invaluable” during pandemic

by | January 19, 2021

How patients can make a real impact with virtual events

by | January 13, 2021

‘COVID-19 survivors are coming out as kidney patients’ 

by | January 6, 2021

Bringing the trial to the patient

by | December 16, 2020

Supporting arthritis patients through the pandemic 

by | December 15, 2020

Stress, anxiety and loneliness: how the pandemic added to the burden of people with dementia  

by | December 8, 2020

Pandemic hits patient engagement 

by | December 3, 2020

Is MedTech ready for patient engagement? 

by | November 23, 2020

COVID-19’s twin threat for cancer patients

by | November 20, 2020

‘Want to discuss patient engagement? Do this training first’

by | November 18, 2020

Patient engagement training: changing company culture one step at a time

by | November 12, 2020

Should a ‘PE license’ be mandatory to work in the medicines ecosystem?

by | October 9, 2020

Novartis leadership support boosts Patient Engagement training for employees

by | October 2, 2020

How COVID-19 changes clinical trials – for good

by | August 31, 2020

The final piece of the puzzle: capacity building in patient engagement

by | June 24, 2020

A shared vision: bringing empowered patients to the table

by | June 22, 2020

Patient information leaflets: “Putting patients’ needs first is vitally important”

by | June 9, 2020

5 minutes with…Doug Noland, Executive Director, Patient Partnerships, Astellas Pharma

by | June 3, 2020

Researchers and patients benefit from co-designing clinical trials – a new guide aims to make it easier to collaborate

by | May 27, 2020

Implementing patient engagement in clinical trial design: challenges and opportunities

by | May 19, 2020

Protecting everyone’s interests: the RAPP project

by | May 13, 2020

Involving patients in drug development – from the start

by | May 12, 2020

Training can help to build capacity for patient engagement

by | May 5, 2020

Ensuring the patient’s voice is heard

by | April 23, 2020

“We need to take patient involvement to new levels”

by | April 21, 2020

‘We need to build infrastructure to support patient-centricity’ 

by | April 15, 2020

‘HTA bodies and regulators have a shared interest in understanding patient experiences’

by | April 8, 2020

Nobody has ever regretted patient engagement

by | March 30, 2020

Plain language summaries now a publishing requirement in drug safety journal

by | February 20, 2020

5 minutes with… Jessica Scott, Head of R&D Patient Engagement Office, Takeda  

by | February 12, 2020

Acknowledging the value of patient input

by | February 5, 2020

5 minutes with… the American Migraine Foundation

by | January 9, 2020

Unlocking the potential of cohort studies

by | October 4, 2019

A PE trailblazer committed to improving patients’ lives

by | September 23, 2019

Developing the patient engagement system

by | September 19, 2019

Doctors are paid for their expertise, what about patients?

by | September 5, 2019

Calculating reimbursement rates for patient engagement in medicines development

by | September 3, 2019

Applying the Patient Engagement Quality Guidance across a whole organisation – the INVOLVE experience

by | August 16, 2019

How the National Kidney Foundation is piloting the PEQG

by | July 25, 2019

Putting patient engagement on the map at ISPOR US

by | July 18, 2019

Making the case for patient engagement

by | July 8, 2019

Patients & partnership: involving citizens in shaping the future of healthcare 

by | July 1, 2019

EU must prioritise patient engagement in health research 

by | June 26, 2019

Piloting the Patient Engagement Quality Guidance in health technology assessment

by | June 18, 2019

How Parkinson’s UK is piloting the Patient Engagement Quality Guidance

by | June 11, 2019

EU researchers to have access to ‘pool’ of patient experts

by | June 3, 2019

FDA calls on industry to speed up trials process

by | April 29, 2019

New medicines 19% more likely to launch when trials are co-designed with patients

by | April 24, 2019

Wisdom of the crowd: how the public can help decide what research to fund

by | April 4, 2019

Different patients, different solutions: PFMD at the EFGCP Annual Meeting

by | March 18, 2019

The wide-ranging impact of patient access

by | February 27, 2019

Patient health data: translating stories into science

by | April 25, 2022

Determining Fair Market Value: Demystifying the methodology behind patient remuneration

by | March 25, 2022

Get the latest information on Patient Focused Medicines Development and stay connected with our activities.